HK Stock Market Move | Robotechnik Intelligent Technology (03757) fell nearly 10%, hitting a new post-listing low; it achieved a net profit of 6.56 million yuan in the first half of the year.
Robotechnik Intelligent Technology (03757) fell over 9%, touching HK$376.4 intraday to hit a new post-listing low.
Robotechnik Intelligent Technology (03757) fell nearly 10%, touching HK$376.4 intraday to hit a new post-listing low. As of press time, it was down 9.81% at HK$377, with a turnover of HK$44.7094 million.
On the news front, Robotechnik Intelligent Technology originally started out in photovoltaic cell automation equipment, and after completing the acquisition of Germany's ficonTEC in 2025, it gained capabilities in photonic chip automated packaging and testing equipment. According to CIC data, based on 2025 revenue, the company ranks first globally in the silicon photonics intelligent manufacturing equipment sector, with a market share of 20.5%.
From a financial perspective, from 2023 to 2025, the company's revenue was RMB 1.570 billion, RMB 1.104 billion, and RMB 949 million, respectively; gross margin rose from 21.9% to 28.7% and 34.5%, but net profit attributable to shareholders was RMB 79 million, RMB 63 million, and a loss of RMB 45 million, respectively. The decline in 2025 revenue was related to fluctuations in the original photovoltaic equipment business and the consolidation and integration pace after the acquisition of ficonTEC. In the first half of this year, revenue was 608 million, up 144.8% year-on-year; net profit was 6.56 million yuan, compared with a loss of 33.33 million yuan in the same period last year.
Related Articles

Shanghai Kehua Bio-engineering (002022.SZ): Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) obtained medical device registration certificate.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): Lyophilized recombinant respiratory syncytial virus vaccine (CHO cell) approved for clinical trials.

IREN (IREN.US) Mysterious Customer Emerges? Anthropic Reportedly Signs Multi-Year Cloud Deal
Shanghai Kehua Bio-engineering (002022.SZ): Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) obtained medical device registration certificate.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): Lyophilized recombinant respiratory syncytial virus vaccine (CHO cell) approved for clinical trials.

IREN (IREN.US) Mysterious Customer Emerges? Anthropic Reportedly Signs Multi-Year Cloud Deal






